FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Alberto Lazaro

Research Profile

Living Beings

Chemicals & Drugs

Disorders

Co-author Network

Publications

TOP 3
Blanca Humanes; Jose M Lara; Alberto Lazaro; Jose A Lazaro; Pablo Martín-Vasallo; Estefanía Moreno-Gordaliza; Alberto Ortiz; Montserrat Blanco-Codesido; Sonia Camano; Maria M Gomez-Gomez; Alberto Tejedor
Cilastatin protects against cisplatin-induced nephrotoxicity without compromising its anticancer efficiency in rats.
Sonia Camano; Alberto Lazaro; Estefania Moreno-Gordaliza; Ana María Torres; Carmen de Lucas; Blanca Humanes; Jose A Lazaro; M Milagros Gomez-Gomez; Lisardo Bosca; Alberto Tejedor
Cilastatin attenuates cisplatin-induced proximal tubular cell damage.
Julio Gallego-Delgado; Alberto Lazaro; Julio Osende; Vanesa Esteban; Maria G Barderas; Carmen Gomez-Guerrero; Ricardo Vega; Fernando Vivanco; jesus egido
Proteomic analysis of early left ventricular hypertrophy secondary to hypertension: modulation by antihypertensive therapies.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Alberto Lazaro (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Blanca Humanes; Jose M Lara; Alberto Lazaro; Jose A Lazaro; Pablo Martín-Vasallo; Estefanía Moreno-Gordaliza; Alberto Ortiz; Montserrat Blanco-Codesido; Sonia Camano; Maria M Gomez-Gomez; Alberto Tejedor
Cilastatin protects against cisplatin-induced nephrotoxicity without compromising its anticancer efficiency in rats.
Kidney international 2012;82(6):652-63.
2010: Sonia Camano; Alberto Lazaro; Estefania Moreno-Gordaliza; Ana María Torres; Carmen de Lucas; Blanca Humanes; Jose A Lazaro; M Milagros Gomez-Gomez; Lisardo Bosca; Alberto Tejedor
Cilastatin attenuates cisplatin-induced proximal tubular cell damage.
The Journal of pharmacology and experimental therapeutics 2010;334(2):419-29.
2006: Julio Gallego-Delgado; Alberto Lazaro; Julio Osende; Vanesa Esteban; Maria G Barderas; Carmen Gomez-Guerrero; Ricardo Vega; Fernando Vivanco; jesus egido
Proteomic analysis of early left ventricular hypertrophy secondary to hypertension: modulation by antihypertensive therapies.
Journal of the American Society of Nephrology : JASN 2006;17(12 Suppl 3):S159-64.
2006: Vanesa Esteban; Julio Gallego-Delgado; Alberto Lazaro; Julio Osende; Sergio Mezzano; jesus egido; Marta Ruiz-Ortega
Long-term treatment with an ACE inhibitor or an AT1 antagonist avoids hypertension-induced inflammation in the kidney.
Journal of nephrology 2006;19(6):725-31.
2006: Julio Gallego-Delgado; Alberto Lazaro; Dulcenombre Gomez-Garre; Julio Osende; Maria L Gonzalez-Rubio; Marta Herraiz; Félix Manzarbeitia; José Fortes; Arturo Fernandez-Cruz; jesus egido
Long-term organ protection by doxazosin and/or quinapril as antihypertensive therapy.
Journal of nephrology 2006;19(5):588-98.
2006: Julio Gallego-Delgado; Alberto Lazaro; Julio Osende; Maria G Barderas; MCarmen Duran; Fernando Vivanco; jesus egido
Comparison of the protein profile of established and regressed hypertension-induced left ventricular hypertrophy.
Journal of proteome research 2006;5(2):404-13.
2005: Julio Gallego-Delgado; Alberto Lazaro; Julio Osende; Maria G Barderas; Luis M Blanco-Colio; MCarmen Duran; Jose Luis Martin-Ventura; Fernando Vivanco; jesus egido
Proteomic approach in the search of new cardiovascular biomarkers.
Kidney international. Supplement 2005;(99):S103-7.
2005: Alberto Lazaro; Julio Gallego-Delgado; Pilar Justo; Vanesa Esteban; Julio Osende; Sergio Mezzano; alberto ortiz; jesus egido
Long-term blood pressure control prevents oxidative renal injury.
Antioxidants & redox signaling 2005;7(9-10):1285-93.